首页> 外文期刊>International Journal of Ayurveda Research >Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy
【24h】

Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy

机译:阿育吠陀疗法治疗复发性未分化急性髓性白血病(AML-M0)

获取原文
       

摘要

A 16-year-old boy was detected with acute myeloid leukemia (AML – M0) with bone marrow pathology showing 85% blasts in February 07, 1997. He received two cycles of induction chemotherapy (3+7 protocol) with daunomycin and cytosar, following which he achieved incomplete remission with bone marrow aspirate showing 14% blasts. Subsequently, the patient received two cycles of high-dose cytosine arabinoside Ara-C and achieved remission. However, his disease relapsed on August 29, 1997. Peripheral blood smear showed 6% blast cells and bone marrow showed 40% blast cells. The patient refused further chemotherapy and/or bone marrow transplant and volunteered for Ayurvedic therapy (AYT) advocated by the author from September 09, 1997. Bone marrow studies done after six months of AYT indicated that the disease was in remission. The AYT was continued for five years and stopped. Thereafter, the patient received intermittent maintenance AYT for three months in the next two years. At present, the patient is normal and healthy and has completed 12 years of disease-free survival with AYT.Keywords: Ayurvedic, relapsed acute myeloid leukemia
机译:1997年2月7日,一名16岁男孩被发现患有急性髓样白血病(AML-M0),骨髓病理显示85%的胚泡。他接受了两个周期的诱导性化疗(3 + 7方案),其中应用了道诺霉素和胞浆,之后,他获得了骨髓吸出物,显示出14%的爆炸,从而获得了不完全缓解。随后,患者接受了两个周期的大剂量胞嘧啶阿拉伯糖苷Ara-C的治疗,并获得缓解。但是,他的病于1997年8月29日复发。外周血涂片显示6%的原始细胞,骨髓显示40%的原始细胞。该患者拒绝进一步化疗和/或骨髓移植,并于1997年9月9日自愿接受作者提倡的印度草药疗法(AYT)。AYT六个月后进行的骨髓研究表明该病已缓解。 AYT持续了五年并停了下来。此后,患者在接下来的两年中接受了为期三个月的间歇性AYT。目前,该患者是正常健康的,使用AYT已完成了12年的无病生存期。关键字:阿育吠陀,复发性急性髓细胞白血病

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号